Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls
Mahsa Ghajarzadeh, Bridget Morris, Nicole Bou Rjeily, Emmanuelle L. Waubant et al.
Citations
1 citations
Journal
Multiple Sclerosis Journal
Topics
Multiple Sclerosis Research Studies
Field-Weighted Citation Impact (FWCI)
1.47
article
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls
Mahsa Ghajarzadeh, Bridget Morris, Nicole Bou Rjeily, Emmanuelle L. Waubant, Alexandra Balshi, Andrea Salazar-Camelo, Bardia Nourbakhsh, Lauren Vega, Yasser Fadlallah, Ellen M Mowry
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Multiple Sclerosis JournalVol. 31(11)
Institutions
Johns Hopkins University (US), University of California, San Francisco (US)